Search - ReachMD

Be part of the knowledge.™

Filter Search Results

Order:

Content Type:

Specialty:

Media Type:

Showing 131-140 of 21392 results for "".

Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
https://reachmd.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56565/
Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.
Location: Palo Alto, California, United States
Date: October 20, 2026; 06:30 PM - 08:30 PM PT
Unmasking HCM in Patients With Preserved EF: Diagnostic Clarity, Evolving Evidence, and Emerging Therapeutic Strategies
https://reachmd.com/live-events/unmasking-hcm-in-patients-with-preserved-ef-diagnostic-clarity-evolving-evidence-and-emerging-therapeutic-strategies/67268/
Join us for breakfast to explore diagnostic challenges in HCM and HFpEF and review emerging evidence for SGLT inhibition and its impact on symptoms and function.
Location: Arizona, United States
Date: October 10, 2026; 12:00 AM - 12:00 AM PT
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
https://reachmd.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56673/
Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.
Location: Austin, Texas, United States
Date: October 22, 2026; 06:30 PM - 08:30 PM CT
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
https://reachmd.com/live-events/todays-cllsll-decisions-tomorrows-options-practical-strategies-for-the-community-clinic/67249/
Explore selection, sequencing & safety strategies for continuous vs fixed-duration therapies in CLL/SLL, including emerging BTK- and BCL2-directed approaches.
Location: Online
Date: September 24, 2026; 06:00 PM - 07:00 PM ET
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
https://reachmd.com/live-events/todays-cllsll-decisions-tomorrows-options-practical-strategies-for-the-community-clinic/60600/
Explore selection, sequencing & safety strategies for continuous vs fixed-duration therapies in CLL/SLL, including emerging BTK- and BCL2-directed approaches. Complimentary lunch will be provided.
Location: Online
Date: September 11, 2026; 12:17 PM - 01:17 PM CT
Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
https://reachmd.com/live-events/closing-the-gap-in-first-line-treatment-of-kras-g12cmutated-advanced-nsclc-from-biology-to-bedside-decisions-and-trial-ready-care/57276/
Improve first-line care for KRAS G12C–mutated advanced NSCLC through timely biomarker testing, personalized treatment strategy, and clinical trial referral.
Location: Online
Date: September 30, 2026; 04:30 PM - 05:15 PM EDT
Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
https://reachmd.com/live-events/closing-the-gap-in-first-line-treatment-of-kras-g12cmutated-advanced-nsclc-from-biology-to-bedside-decisions-and-trial-ready-care/57275/
Improve first-line care for KRAS G12C–mutated advanced NSCLC through timely biomarker testing, personalized treatment strategy, and clinical trial referral.
Location: Online
Date: November 9, 2026; 07:00 PM - 07:45 PM EST
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
https://reachmd.com/live-events/when-mild-matters-most-closing-clinical-gaps-in-early-symptomatic-ad/56416/
Join expert faculty for a worldwide webinar series. Available in multiple languages!
Location: Online
Date: September 10, 2026; 03:00 PM - 04:00 PM ET
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
https://reachmd.com/live-events/when-mild-matters-most-closing-clinical-gaps-in-early-symptomatic-alzheimers-disease/60978/
Join expert faculty for a worldwide webinar series. Available in multiple languages!
Location: Online
Date: October 7, 2026; 06:00 PM - 07:00 PM CEST
Push Past in AD: Treatment Escalation in Moderate to Severe Atopic Dermatitis—A Regional Workshop Series for Advanced Practice Providers
https://reachmd.com/live-events/push-past-in-ad-treatment-escalation-in-moderate-to-severe-atopic-dermatitisa-regional-workshop-series-for-advanced-practice-providers/57111/
Learn how to assess atopic dermatitis severity and apply guideline-aligned strategies to optimize treatment selection for moderate to severe disease.
Location: New York, New York, United States
Date: November 3, 2026; 07:00 PM - 08:30 PM ET

Program Chapters

Segment Chapters

Playlist:

Recommended